-
Europe's biggest private biotech company raises $270 million
biospectrumasia
November 29, 2018
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalized immunotherapies for cancer...
-
BioNTech: MammaTyper? Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer (BC)
b3cnewswire
November 29, 2018
BioNTech Diagnostics GmbH announced new results from a clinical performance evaluation study of the CE-marked IVD?MammaTyper??which were presented at the European Society for Medical Oncology (ESMO) in Munich in October.(1,2)
-
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
pharmafocusasia
November 27, 2018
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease...
-
Pfizer Signs $425m Flu Vaccine Deal with BioNTech
contractpharma
August 21, 2018
BioNTech AG, a biotech focused on precise immunotherapies for the treatment of cancer and infectious disease, has entered into a multi-year R&D collaboration with?Pfizer?to develop mRNA-based vaccines for prevention of influenza (flu).
-
Pfizer pays BioNTech $120M upfront to form mRNA flu vaccine pact
fiercebiotech
August 17, 2018
Pfizer has?struck?a $425 million deal to work with BioNTech on the development of mRNA influenza vaccines. The Big Pharma is providing $120 million in upfront and near-term payments to enter into the R&D collaboration.
-
Europe's biggest private biotech company raises $270 million
biospectrumasia
April 04, 2018
Europe's biggest private biotech company raises $270 million BioNTech has already signed a $310 million deal with Roche
-
Europe's biggest private biotech company raises $270 million
en-cphi.cn
February 06, 2018
BioNTech has raised $270 million to support its work in developing personalized immunotherapies for cancer, ahead of an expected eventual stock market flotation.
-
Biontech brings antibody production into the body
epvantage
June 13, 2017
Antibodies have transformed the treatment landscape in many diseases, but are time-consuming and expensive to make. Prod
-
BioNTech Announces Positive Results of an International Reproducibility Study with MammaTyper?
b3cnewswire
May 16, 2017
BioNTech Diagnostics GmbH today announced the publication of an international prospective multicenter study that demonstrates the high reproducibility of the MammaTyper? in vitro diagnostic test.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
